| Efficacy of indomethacin 0.1% and fluorometholone 0.1% on conjunctival inflammation following chronic application of antiglaucomatous drugs. | |
| | |
MedLine Citation:
|
PMID: 12486516 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: Subclinical conjunctival inflammation has been shown to have a deleterious effect on the outcome of filtering surgery. The study was designed to assess the efficacy and safety of a non-steroidal anti-inflammatory ophthalmic solution (preservative-free indomethacin 0.1%) on conjunctival inflammation following chronic application of antiglaucomatous drugs, in comparison with a steroidal ophthalmic solution (preserved fluorometholone). METHODS: Eighty-nine glaucomatous patients were included in a randomised, multicentre study comparing two parallel groups of treatment given on the basis of 1 drop 4 times daily for 1 month before filtering surgery. Patients had been treated with one or more antiglaucomatous drugs for at least 3 years. The routine antiglaucomatous treatment was continued during the study. Evaluations were carried out at baseline and after 30 days of treatment. Conjunctival inflammation was assessed under masked conditions by means of conjunctival impression analysis which determined the percentage of cells expressing HLA-DR. The ocular surface was also examined using the fluorescein test and lissamine green staining. RESULTS: Paired conjunctival impression specimens available both on day 0 (D0) and day 30 (D30) involved 49 patients. Among them, 34 eyes had a positive expression of HLA-DR at inclusion. On D30, in patients positive to HLA-DR on D0, the percentage of cells expressing HLA-DR had significantly decreased in both treatment groups: the mean reduction was 29.7% from a baseline value of 51.4% in the indomethacin group ( P=0.019) and 32.5% from a baseline value of 48.7% in the fluorometholone group ( P<0.001). There was no significant difference between groups. Seven cases of drug-related superficial punctate keratitis were observed on D30 by means of a fluorescein test: one in the indomethacin group and six in the fluorometholone group. CONCLUSION: Both anti-inflammatory eyedrops were effective in reducing subclinical conjunctival inflammation before filtering surgery. Regarding superficial punctate keratitis, the corneal tolerance of preservative-free indomethacin 0.1% eyedrops seemed to be better than that of preserved fluorometholone eyedrops. |
| | |
Authors:
|
Christophe Baudouin; Jean-Philippe Nordmann; Philippe Denis; Catherine Creuzot-Garcher; Catherine Allaire; Claude Trinquand |
Related Documents
:
|
2292326 - Evaluation of the efficacy and safety of sobrerol granules in patients suffering from c... 18616726 - Topical diclofenac 3% gel plus cryotherapy for treatment of multiple and recurrent acti... 16504956 - Efficacy and tolerability of a spray with salvia officinalis in the treatment of acute ... 16005336 - Acupuncture in patients with osteoarthritis of the knee: a randomised trial. 17611456 - Analysis of complications following total knee replacement with a cemented condylar end... 11515726 - Morbidity and mortality associated with vasopressin replacement therapy in children. |
Publication Detail:
|
Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial Date: 2002-10-30 |
Journal Detail:
|
Title: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv für klinische und experimentelle Ophthalmologie Volume: 240 ISSN: 0721-832X ISO Abbreviation: Graefes Arch. Clin. Exp. Ophthalmol. Publication Date: 2002 Nov |
Date Detail:
|
Created Date: 2002-12-17 Completed Date: 2003-02-04 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 8205248 Medline TA: Graefes Arch Clin Exp Ophthalmol Country: Germany |
Other Details:
|
Languages: eng Pagination: 929-35 Citation Subset: IM |
Affiliation:
|
Hôpital A. Paré, Boulogne-Billancourt, France. baudouin@quinze-vingts.fr |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Aged Anti-Inflammatory Agents / adverse effects, therapeutic use* Anti-Inflammatory Agents, Non-Steroidal / adverse effects, therapeutic use* Chronic Disease Conjunctiva / immunology Conjunctivitis / complications, drug therapy*, immunology Female Fluorometholone / adverse effects, therapeutic use* Glaucoma / complications, drug therapy HLA-DR Antigens / metabolism Humans Indomethacin / adverse effects, therapeutic use* Keratitis / chemically induced Male Middle Aged Ophthalmic Solutions / therapeutic use Prospective Studies Single-Blind Method Treatment Outcome |
| Chemical | |
Reg. No./Substance:
|
0/Anti-Inflammatory Agents; 0/Anti-Inflammatory Agents, Non-Steroidal; 0/HLA-DR Antigens; 0/Ophthalmic Solutions; 426-13-1/Fluorometholone; 53-86-1/Indomethacin |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Tear osteopontin levels in patients with allergic conjunctival diseases.
Next Document: Nitric oxide/guanylate cyclase pathways and flow in anterior segment perfusion.